Loading live market data…

CytomX Therapeutics, Inc.

NASDAQ:CTMX

$3.64 USD

-$0.02 (-0.55%)

Volume
1.6M
Average Volume
4.32M
Market Capitalization
$585.4M
P/E Ratio
-10.08
Dividend Yield
0.00%
Price Target
$10.00
Year High
$8.21
Year Low
$1.72
Day High
—
Day Low
—
Payout Ratio
$0.00
Current Ratio
$10.38

CTMX Estimated and Actual Revenue by Quarter

CTMX Estimated and Actual EPS by Quarter

CTMX Analyst Forecasts

Quarter Date No of Estimates Ebitda Ebit
Low High Average Low High Average
2027-12-31 3 -1.87M -753.62K -1.31M -1.92M -774.31K -1.35M
2027-09-30 2 -1.87M -753.62K -1.31M -1.92M -774.31K -1.35M
2027-06-30 2 -1.96M -790.12K -1.38M -2.01M -811.8K -1.41M
2027-03-31 3 -2.23M -899.6K -1.57M -2.29M -924.3K -1.61M
2026-12-31 3 -3.86M -1.56M -2.71M -3.97M -1.6M -2.79M
2026-09-30 4 -3.39M -1.37M -2.38M -3.48M -1.4M -2.44M
Quarter Date No of Estimates NetIncome SgaExpense
Low High Average Low High Average
2027-12-31 3 -44.94M -12.92M -28.95M 1.09M 2.71M 1.9M
2027-09-30 2 -42.19M -12.13M -27.18M 1.09M 2.71M 1.9M
2027-06-30 2 -38.52M -11.08M -24.82M 1.14M 2.84M 1.99M
2027-03-31 3 -35.77M -10.28M -23.05M 1.3M 3.23M 2.27M
2026-12-31 3 -31.01M -8.92M -19.98M 2.25M 5.59M 3.92M
2026-09-30 4 -22.81M -17.55M -19.3M 1.98M 4.9M 3.44M
Quarter Date No of Revenue Estimates Revenue No of EPS Estimates EPS
Low High Average Low High Average
2027-12-31 3 1.98M 4.9M 3.44M 2 -0.25353 -0.07288906 -0.16333
2027-09-30 2 1.98M 4.9M 3.44M 1 -0.238 -0.06842637 -0.15333
2027-06-30 2 2.07M 5.14M 3.61M 1 -0.21731 -0.06247761 -0.14
2027-03-31 3 2.36M 5.85M 4.11M 2 -0.20179 -0.05801493 -0.13
2026-12-31 3 4.08M 10.13M 7.11M 2 -0.17495 -0.05029894 -0.11271
2026-09-30 4 3.58M 8.88M 6.24M 4 -0.12868 -0.09898182 -0.10888